General

Final Decision Regarding Petition for Insomnia to be included as a qualifying condition for enrollment in the Medical Cannabis Program

This fee schedule will be updated on an annual basis to reflect the most current service payments for the HIV Services Dental Program.

Both the CDC and FDA are reporting national shortages of Benzathine penicillin G (Bicillin L-A®) due to increased demand: FDA Drug Shortages and CDC - STD Treatment - Drug notices. The FDA anticipates the issue will be resolved by the fourth quarter of this year. There are no emergency stockpiles of this medication and existing supplies are very limited.

The New Mexico Department of Health (NMDOH) is seeing low influenza activity statewide and considers the need for seasonal precautions for the prevention of influenza to be over. Moving forward, only occasional and isolated cases of influenza are likely to occur. However, with sporadic influenza activity, it is still possible to see rare summer-time outbreaks of influenza-like illness (ILI), and COVID-19 activity remains unpredictable. ILI is defined as fever of greater than 100° F and cough and/or sore throat in the absence of another known cause. An influenza outbreak is defined as one confirmed case of influenza (by PCR test) and any other cases of ILI in the same geographic location. Since flu circulation is likely to be low outside of the main respiratory season, any rapid positive influenza results should be confirmed by PCR before declaring an outbreak. Outbreaks should be reported to the on-call epidemiologist 24/7/365 at (505) 827-0006.

Department of Public Safety Announcement Letter April 10, 2023

Department of Public Safety Announcement Letter April 17, 2023

Department of Public Safety Announcement Letter April 21, 2023

Department of Public Safety Announcement Letter April 27, 2023

Caregiver Criminal History Screening Program Letter April 28, 2023

Overview of IDEMIA New Mexico Applicant Solution PowerPoint

New Mexico Application Registration Process

New Mexico Non-Resident/Fingerprint Card Scan Overview PowerPoint

Fingerprint background check services Frequently Asked Questions (FAQs)

Map of Fingerprint Location Sites

List of acceptable IDs needed for enrollment

Guidance on Multi-factor Authentication Applications

IDEMIA Background Check Result Access PowerPoint

Northwest Region Health Promotion Team

The CDC and FDA have streamlined COVID-19 vaccine recommendations, authorizing the use of bivalent COVID-19 vaccines for all recommended doses. In addition, previously unvaccinated individuals ages 6 and older are now recommended to receive one dose of a bivalent COVID-19 vaccine, and people ages 65 and older and those with immune compromise can receive a second bivalent vaccine. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.

COVID-19

COVID-19 Factsheet (English)
COVID-19 Factsheet (Spanish)